PLCL1
Inactive phospholipase C-like protein 1
Also known as: PLC-L, PLCE, PLCL, PLCL1_HUMAN, PPP1R127, PRIP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15111
- Gene
- PLCL1
- Ensembl
- ENSG00000115896
- Chromosome
- 2
- Canonical length
- 1095 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable GABA receptor binding activity and phosphatidylinositol-4,5-bisphosphate phospholipase C activity. Predicted to be involved in several processes, including gamma-aminobutyric acid signaling pathway; negative regulation of cold-induced thermogenesis; and phosphatidylinositol-mediated signaling. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1095 residues, UniProt reviewed canonical sequence.
>Q15111|PLCL1
1 MAEGAAGRED PAPPDAAGGE DDPRVGPDAA GDCVTAASGG RMRDRRSGVA LPGAAGTPAD
61 SEAGLLEAAR ATPRRSSIIK DPSNQKCGGR KKTVSFSSMP SEKKISSAND CISFMQAGCE
121 LKKVRPNSRI YNRFFTLDTD LQALRWEPSK KDLEKAKLDI SAIKEIRLGK NTETFRNNGL
181 ADQICEDCAF SILHGENYES LDLVANSADV ANIWVSGLRY LVSRSKQPLD FMEGNQNTPR
241 FMWLKTVFEA ADVDGNGIML EDTSVELIKQ LNPTLKEAKI RLKFKEIQKS KEKLTTRVTE
301 EEFCEAFCEL CTRPEVYFLL VQISKNKEYL DANDLMLFLE AEQGVTHITE DICLDIIRRY
361 ELSEEGRQKG FLAIDGFTQY LLSSECDIFD PEQKKVAQDM TQPLSHYYIN ASHNTYLIED
421 QFRGPADING YIRALKMGCR SVELDVSDGS DNEPILCNRN NMTTHVSFRS VIEVINKFAF
481 VASEYPLILC LGNHCSLPQQ KVMAQQMKKV FGNKLYTEAP LPSESYLPSP EKLKRMIIVK
541 GKKLPSDPDV LEGEVTDEDE EAEMSRRMSV DYNGEQKQIR LCRELSDLVS ICKSVQYRDF
601 ELSMKSQNYW EMCSFSETEA SRIANEYPED FVNYNKKFLS RIYPSAMRID SSNLNPQDFW
661 NCGCQIVAMN FQTPGPMMDL HTGWFLQNGG CGYVLRPSIM RDEVSYFSAN TKGILPGVSP
721 LALHIKIISG QNFPKPKGAC AKGDVIDPYV CIEIHGIPAD CSEQRTKTVQ QNSDNPIFDE
781 TFEFQVNLPE LAMIRFVVLD DDYIGDEFIG QYTIPFECLQ PGYRHVPLRS FVGDIMEHVT
841 LFVHIAITNR SGGGKAQKRS LSVRMGKKVR EYTMLRNIGL KTIDDIFKIA VHPLREAIDM
901 RENMQNAIVS IKELCGLPPI ASLKQCLLTL SSRLITSDNT PSVSLVMKDS FPYLEPLGAI
961 PDVQKKMLTA YDLMIQESRF LIEMADTVQE KIVQCQKAGM EFHEELHNLG AKEGLKGRKL
1021 NKATESFAWN ITVLKGQGDL LKNAKNEAIE NMKQIQLACL SCGLSKAPSS SAEAKSKRSL
1081 EAIEEKESSE ENGKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLCL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 38 nTPM
Expression across tissuesHPA
Tissue
- tongue: 38 nTPM
- heart muscle: 30 nTPM
- kidney: 29 nTPM
- skeletal muscle: 29 nTPM
- spinal cord: 28 nTPM
- midbrain: 17 nTPM
Single-cell type
- distal convoluted tubule cells: 2,271 nCPM
- oligodendrocytes: 2,121 nCPM
- endometrial stromal cells: 1,975 nCPM
- pituicytes/fscs: 1,901 nCPM
- renal collecting duct intercalated cells: 1,874 nCPM
- choroid plexus epithelial cells: 1,514 nCPM
Immune cell
- T-reg: 1.4 nTPM
- MAIT T-cell: 0.7 nTPM
- memory CD4 T-cell: 0.6 nTPM
- naive CD4 T-cell: 0.4 nTPM
- neutrophil: 0.2 nTPM
- gdT-cell: 0.1 nTPM
Brain region
- white matter: 143 nTPM
- medulla oblongata: 101 nTPM
- basal ganglia: 95 nTPM
- midbrain: 90 nTPM
- pons: 86 nTPM
- cerebellum: 80 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.86
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- gamma-aminobutyric acid signaling pathway
- intracellular signal transduction
- negative regulation of cold-induced thermogenesis
- phosphatidylinositol metabolic process
- phosphatidylinositol-mediated signaling
- regulation of synaptic transmission, GABAergic
- release of sequestered calcium ion into cytosol
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Phosphatidylinositol-specific phospholipase C, X domain
- Phosphoinositide phospholipase C family
- Phospholipase C, phosphatidylinositol-specific, Y domain
- Pleckstrin homology domain
- EF-hand domain pair
- PH-like domain superfamily
- Phosphoinositide-specific phospholipase C, EF-hand-like domain
- PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily
- C2 domain superfamily
- C2 domain
- Phosphatidylinositol-specific phospholipase C, Y domain
- Phosphatidylinositol-specific phospholipase C, X domain
- Phosphoinositide-specific phospholipase C, efhand-like
- Pleckstrin homology domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLCL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLCL1 as an antibody target. Whether an autoantibody or antibody against PLCL1 could matter depends on whether native PLCL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLCL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLCL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...